Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-016779-31-DE
EUCTR2009-016779-31-DE
Active, not recruiting
Not Applicable

A Trial Investigating the Pharmacokinetic Properties ofNN5401 in Children, Adolescents and Adults with Type1 Diabetes

ovo Nordisk A/S0 sitesJanuary 27, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ovo Nordisk A/S
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 27, 2010
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Male or female aged 6\-65 years (both inclusive)
  • •Type 1 diabetes mellitus (as diagnosed clinically) \= 12 months
  • •Body mass index for children and adolescents (male and female) between the 3\. and 97\. BMI percentile and for adults \= 30\.0 kg/m2\.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Subject who has donated any blood or plasma in the past month, or more than
  • •500 mL within 3 months prior to screening
  • •Not able or willing to refrain from smoking during the inpatient period
  • •Female of childbearing potential who is pregnant, breast\-feeding or intends to
  • •become pregnant or is not using adequate contraceptive methods

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 DiabetesType I diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitus
EUCTR2008-008306-43-DEovo Nordisk A/S
Active, not recruiting
Not Applicable
A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2011-002104-32-DEovo Nordisk A/S
Active, not recruiting
Not Applicable
The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaDiseases of the circulatory system
KCT0001258Hanlim Pharmaceutical40
Completed
Not Applicable
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402
KCT0003213avipharm38
Not yet recruiting
Not Applicable
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous system
KCT0004878Woosung Pharma27